Antiepileptic drugs and bone metabolism - Wikidata - awgldk - TriplyDB

Antiepileptic drugs and bone metabolism

Antiepileptic drugs and bone metabolism

http://www.wikidata.org/entity/Q21245075

about

Impact of antiepileptic drugs on bone health: Need for monitoring, treatment, and prevention strategies Prenatal exposure to lamotrigine: effects on postnatal development and behaviour in rat offspring Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients.Rational approach to treatment options for Lennox-Gastaut syndrome.Medication-induced osteoporosis: screening and treatment strategies Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.Diagnosis and treatment of vitamin D deficiency.Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI)Influence of drugs on vitamin D and calcium metabolism Phenytoin Induced Osteopathy -Too Common to be Neglected.Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report.Evidence-based review of bone strength in children and youth with cerebral palsy.Bone loss associated with use of antiepileptic drugs.Epileptic seizure, as the first symptom of hypoparathyroidism in children, does not require antiepileptic drugs.The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations.Epilepsy and vitamin D.Practice implications for preventing population vulnerability related to vitamin D status.Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double-blind studies.Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.Bone Mineral Status in Children with Epilepsy: Biochemical and Radiologic Markers.Characteristics of 22q 11.2 deletion syndrome undiagnosed until adulthood: an example suggesting the importance of psychiatric manifestations.Bone Health in Patients with Epilepsy: A Community-based Pilot Nested Case-control Study.Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice.BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.Evaluation of bone health among epileptic patients using biochemical markers and DEXA scan: an Egyptian study

P2860

Q28074005-E2DD1C73-1F2A-460A-915F-69B8D8E1260D Q33711330-CEF72B92-5012-47EC-8203-EB86C2AFA89F Q33861621-4CA32578-99D8-42E3-A260-5D0E529DD44B Q33971818-474F55E7-378F-405A-B5BD-8BF25D91CC56 Q34389358-7313F887-81C9-409F-AC89-FD81D5F4123E Q34443523-04B0816C-C446-4AAD-9A0E-4B1C23D72722 Q34724756-23501754-F8F3-4095-BE53-2BDA69E35731 Q35156078-2F9C886B-9003-4B77-AF34-3DB97C79CFB3 Q36187610-A0F6312E-B5DF-4D23-8E3E-601C80F5A76F Q36343589-BD7AC553-D4CD-43FD-B2A5-826C5CD6A9A6 Q37338208-5DAA1BE6-E849-4319-BA94-4310F9389B49 Q37423494-90372CA8-2B96-44F1-B359-9D3B3B89996E Q37702229-71F7153D-B220-4FD4-843D-AC846B09D1B6 Q37703170-A9F904E7-2761-4137-A7AE-B52AE27AFBEC Q37838799-1E3BFEB0-2EF7-41AB-A8B9-B0ABB7A28017 Q38142332-EEE72537-2990-443E-BE56-9437D7253030 Q38161856-27F10A7D-1A39-4B5E-A0AE-9BB459BF115A Q39015100-4209BD57-941B-48C7-B1EC-4C78102CD51F Q39030320-EBB1C5B9-F2C0-41FC-AB4C-79FA5937A6AA Q41593934-4B6D5C7A-0DAA-4ACE-A9CE-81E5CDAC0B70 Q42264612-2778FC59-BAAA-40FB-8291-712987B690D7 Q47149393-DB8AAA7B-636C-4E2D-80E8-D6AB296790C2 Q51143850-5535D028-F764-4B7C-8823-FA3A4BB1A350 Q51399526-CE4AC7C8-291B-4F57-B4C7-8377C39B74CA Q56604475-9CE6790C-E06F-4F11-A42F-C953F42D5862

P2860

Antiepileptic drugs and bone metabolism

http://www.wikidata.org/entity/Q21245075

description

2006 nî lūn-bûn

@nan

2006 թուականին հրատարակուած գիտական յօդուած

@hyw

2006 թվականին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Antiepileptic drugs and bone metabolism

@ast

Antiepileptic drugs and bone metabolism

@en

Antiepileptic drugs and bone metabolism

@en-gb

Antiepileptic drugs and bone metabolism

@nl

type

label

Antiepileptic drugs and bone metabolism

@ast

Antiepileptic drugs and bone metabolism

@en

Antiepileptic drugs and bone metabolism

@en-gb

Antiepileptic drugs and bone metabolism

@nl

prefLabel

Antiepileptic drugs and bone metabolism

@ast

Antiepileptic drugs and bone metabolism

@en

Antiepileptic drugs and bone metabolism

@en-gb

Antiepileptic drugs and bone metabolism

@nl

P1433

Q21245075-323962D8-4FAA-4CDA-AE25-2D9A065DAEB0

P1476

Q21245075-ACC86ECF-EC9E-4E32-B837-95234E71E04C

P2093

Q21245075-2D73DD50-811F-4068-BABB-CED1A10EC90C

Q21245075-5809F8D0-5738-4C59-B8A4-73FA1E84F767

Q21245075-5B44407A-D423-4A9B-9399-30D42DAA5C05

Q21245075-CDE4560D-376B-4815-B665-0063FED707A6

P2860

Q21245075-08DF9DAE-FDD7-4C89-8A11-2815777C7BC0

Q21245075-24C58692-B92C-4C06-A567-A0BBF1EFA0D3

Q21245075-262646D1-AB2E-42AB-B994-B051BC344421

Q21245075-365CE7E1-EBB3-451B-BE24-A0418CA16E15

Q21245075-385C0864-0A3A-4715-91C0-3E4F861A6D27

Q21245075-3B46FACC-ADB8-42B3-BD24-031FA191DCB0

Q21245075-3BE1A4CF-9410-46EC-99E2-745D149BD777

Q21245075-57E32BBB-DA20-4159-9D21-85F40681557F

Q21245075-6336B738-784E-4765-9D64-0A663E6CAC27

Q21245075-6619F709-E13A-43E2-8AB3-48167E962AC6

P2888

Q21245075-9D7B0AD2-5148-4B2D-B1DD-0438F37BA9DC

P304

Q21245075-B0042A1C-C8F0-46DC-926E-9E1039390560

P31

Q21245075-3ADC3D3F-51AC-4D37-A872-21A69A87A62B

P3181

Q21245075-F901663E-C76D-41DF-9207-5C035DD0C804

P356

Q21245075-555C7EF1-C3BF-477B-BDB9-BCF2722BBAC1

P407

Q21245075-BCC85205-EFAF-4E5C-A381-20140B1A8A25

P433

Q21245075-62A197D1-366D-4ED6-BB6C-D7884C0F7668

P478

Q21245075-871A502C-19CD-4E85-9ABD-FBF4A6EE68F9

P577

Q21245075-051FB515-F405-4FE7-A380-B4A4DB52C97F

P5875

Q21245075-BA1B5ACE-2CB8-4417-B63D-844F355F945D

P6179

Q21245075-E064171D-FC1A-4EEC-9A86-06D2FA32ED23

P698

Q21245075-24B81BF4-621D-45C3-A641-88A0B84AE853

P921

Q21245075-D1697796-DE08-461E-9318-475A187DB12C

P932

Q21245075-3BC4C856-BF31-4E89-9D1D-CCF1D7EDCAD6

P3181

P356

P1433

Nutrition and Metabolism

P1476

Antiepileptic drugs and bone metabolism

@en

P2093

Barbara Labban

http://www.w3.org/2001/XMLSchema#string

Helen A Valsamis

http://www.w3.org/2001/XMLSchema#string

Samy I McFarlane

http://www.w3.org/2001/XMLSchema#string

Surender K Arora

http://www.w3.org/2001/XMLSchema#string

P2860

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature.

Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine.

Stay tuned to PXR: an orphan actor that may not be D-structive only to bone.

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.

Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications.

Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.

Strategies for optimizing antiepileptic drug therapy in elderly people.

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

Aromatase in bone: roles of Vitamin D3 and androgens.

P2888

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4917492

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1743-7075-3-36

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6834713

http://www.w3.org/2001/XMLSchema#string

P6179

1044542480

http://www.w3.org/2001/XMLSchema#string

P698

16956398

http://www.w3.org/2001/XMLSchema#string

P921

human nutrition

P932

1586194

http://www.w3.org/2001/XMLSchema#string